Aldeyra Therapeutics (ALDX) Q4 2021 Earnings Call Transcript
With me is Dr. Todd Brady, president and chief executive officer of Aldeyra. Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include, but are not limited to statements regarding submission of potential new drug applications, potential commercialization, the anticipated timing of results from our clinical trials, our projected cash runway, our possible or assumed future results of operations, expenses and financial position, and potential growth opportunities.